Brachytherapy
Volume 9, Issue 4 , Pages 289-292, October 2010

Point: The relationship between postimplant dose metrics and biochemical no evidence of disease following low dose rate prostate brachytherapy: Is there an elephant in the room?

  • W. James Morris

      Affiliations

    • Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6. Tel.: +1-604-877-6000.
    • ,
  • Ross Halperin

      Affiliations

    • Department of Radiation Oncology, British Columbia Cancer Agency, Kelowna, BC, Canada
    • ,
  • Ingrid Spadinger

      Affiliations

    • Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada

published online 27 August 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(10)00299-0

doi:10.1016/j.brachy.2010.08.002

Brachytherapy
Volume 9, Issue 4 , Pages 289-292, October 2010

Article Tools